Boston Scientific Corp (BSX)vsElectromed Inc (ELMD)
BSX
Boston Scientific Corp
$48.55
-0.34%
HEALTHCARE · Cap: $70.87B
ELMD
Electromed Inc
$37.69
+2.64%
HEALTHCARE · Cap: $312.08M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 28630% more annual revenue ($20.61B vs $71.75M). BSX leads profitability with a 17.3% profit margin vs 14.1%. ELMD appears more attractively valued with a PEG of 0.35. BSX earns a higher WallStSmart Score of 76/100 (B+).
BSX
Strong Buy76
out of 100
Grade: B+
ELMD
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-29.4%
Fair Value
$37.35
Current Price
$48.55
$11.20 premium
Margin of Safety
-63.4%
Fair Value
$15.46
Current Price
$37.69
$22.23 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Strong operational efficiency at 20.6%
Growing faster than its price suggests
Earnings expanding 66.7% YoY
Safe zone — low bankruptcy risk
Every $100 of equity generates 21 in profit
Strong operational efficiency at 20.3%
18.4% revenue growth
Areas to Watch
No major concerns identified
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bull Case : ELMD
The strongest argument for ELMD centers on PEG Ratio, EPS Growth, Altman Z-Score. Revenue growth of 18.4% demonstrates continued momentum. PEG of 0.35 suggests the stock is reasonably priced for its growth.
Bear Case : BSX
No major red flags identified for BSX, but monitor valuation.
Bear Case : ELMD
The primary concerns for ELMD are P/E Ratio, Market Cap.
Key Dynamics to Monitor
BSX profiles as a mature stock while ELMD is a growth play — different risk/reward profiles.
BSX carries more volatility with a beta of 0.62 — expect wider price swings.
ELMD is growing revenue faster at 18.4% — sustainability is the question.
BSX generates stronger free cash flow (171M), providing more financial flexibility.
Bottom Line
BSX scores higher overall (76/100 vs 66/100), backed by strong 17.3% margins and 11.6% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Electromed Inc
HEALTHCARE · MEDICAL DEVICES · USA
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation (HFCWO) therapy in lung care for patients of all ages in the United States. and internationally. The company is headquartered in New Prague, Minnesota.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?